The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
Abstract
Berberine (BBR) has been shown to improve several metabolic disorders, such as obesity, type 2 diabetes, and dyslipidemia, by stimulating AMP-activated protein kinase (AMPK). However, the effects of BBR on proinflammatory responses in macrophages are poorly understood. Here we show that BBR represses proinflammatory responses through AMPK activation in macrophages. In adipose tissue of obese db/db mice, BBR treatment significantly downregulated the expression of proinflammatory genes such as TNF-α, IL-1β, IL-6, monocyte chemoattractant protein-1 (MCP-1), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2). Consistently, BBR inhibited LPS-induced expression of proinflammatory genes including IL-1β, IL-6, iNOS, MCP-1, COX-2, and matrix metalloprotease-9 in peritoneal macrophages and RAW 264.7 cells. Upon various proinflammatory signals including LPS, free fatty acids, and hydrogen peroxide, BBR suppressed the phosphorylation of MAPKs, such as p38, ERK, and JNK, and the level of reactive oxygen species in macrophages. Moreover, these inhibitory effects of BBR on proinflammatory responses were abolished by AMPK inhibition via either compound C, an AMPK inhibitor, or dominant-negative AMPK, implying that BBR would downregulate proinflammatory responses in macrophages via AMPK stimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Xie, Z., Zhang, J., Wu, J., Viollet, B., & Zou, M.-H. (2008) · Diabetes · doi:10.2337/db08-0610 · Cited by 163
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 10×
“These cytokines provoke insulin resistance in adipocytes by activating several pathways including PKC, IKK, and JNK (11, 19).”
BackgroundInfluentialInflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“Inflammation is also known to trigger atherosclerosis, a coronary artery disease the hallmark of which is the formation of fatty deposits inside the artery walls (17, 35, 36).”
BackgroundKyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard, J., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J., & Fève, B. (2006) · PubMed · Cited by 2,496
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056
Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J.-M., Lee, C. H., Oh, W. K., Kim, C. T., et al. (2006) · Diabetes · doi:10.2337/db06-0006 · Cited by 1,054
Self-citationLumeng, C. N., DeYoung, S. M., Bodzin, J. L., & Saltiel, A. R. (2007) · Diabetes · doi:10.2337/db06-1076 · Cited by 1,016
Reactive oxygen species and cell signaling: Respiratory burst in macrophage signaling
Forman, H. J., & Torres, M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2206007 · Cited by 891
Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai, S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251608.09329.9a · Cited by 812
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 803
The anti-inflammatory potential of berberine in vitro and in vivo
Kuo, C.-L., Chi, C.-W., & Liu, T.-Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.09.002 · Cited by 685
Redox signaling and the MAP kinase pathways
Torres, M., & Forman, H. J. (2003) · BioFactors · doi:10.1002/biof.5520170128 · Cited by 580
Turner, N., Li, J.-Y., Gosby, A., To, S. W. C., Cheng, Z., Miyoshi, H., Taketo, M. M., Cooney, G. J., Kraegen, E. W., James, D. E., et al. (2008) · Diabetes · doi:10.2337/db07-1552 · Cited by 535
Hsu, H.-Y., & Wen, M.-H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111883200 · Cited by 519 · cited 2×
“It has been well established that proinflammatory stimuli such as LPS and TNF- promote an early and acute increase of cellular ROS levels (13, 21) that stimulate MAPK cascade and downstream transcriptional factors to mediate inflammatory responses (13, 21, 50).”
BackgroundResultHattori, Y., Suzuki, K., Hattori, S., & Kasai, K. (2006) · Hypertension · doi:10.1161/01.hyp.0000221429.94591.72 · Cited by 487
Nguyen, M. T. A., Satoh, H., Favelyukis, S., Babendure, J. L., Imamura, T., Sbodio, J. I., Zalevsky, J., Dahiyat, B. I., Chi, N.-W., & Olefsky, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504611200 · Cited by 411
Berberine improves glucose metabolism through induction of glycolysis
Yin, J., Gao, Z., Liu, D., Liu, Z., & Ye, J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00211.2007 · Cited by 411
Schmeller, T., Latz-Brüning, B., & Wink, M. (1997) · Phytochemistry · doi:10.1016/s0031-9422(96)00545-6 · Cited by 409
Chan, E. D., & Riches, D. W. H. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c441 · Cited by 353
Brusq, J.-M., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y., & Issandou, M. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600020-jlr200 · Cited by 343
In Vitro Antioxidant Studies on the Benzyl Tetra Isoquinoline Alkaloid Berberine
Shirwaikar, A., Shirwaikar, A., Rajendran, K., & Punitha, I. S. R. (2006) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.29.1906 · Cited by 329
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Huang, C., Zhang, Y., Gong, Z., Sheng, X., Li, Z., Zhang, W., & Qin, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.095 · Cited by 278
Giri, S., Nath, N., Smith, B., Viollet, B., Singh, A. K., & Singh, I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4288-03.2004 · Cited by 265
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK
Cheng, Z., Pang, T., Gu, M., Gao, A.-H., Xie, C.-M., Li, J.-Y., Nan, F.-J., & Li, J. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.007 · Cited by 240
Ceolotto, G., Gallo, A., Papparella, I., Franco, L., Murphy, E., Iori, E., Pagnin, E., Fadini, G. P., Albiero, M., Semplicini, A., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.155762 · Cited by 229
Reactive oxygen intermediates in TNF signaling
Garg, A. K., & Aggarwal, B. B. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00207-9 · Cited by 228
Stienstra, R., Duval, C., Keshtkar, S., van der Laak, J., Kersten, S., & Müller, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710314200 · Cited by 190
Berberine stimulates glucose transport through a mechanism distinct from insulin
Zhou, L., Yang, Y., Wang, X., Liu, S., Shang, W., Yuan, G., Li, F., Tang, J., Chen, M., & Chen, J. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.025 · Cited by 187
Woo, C.-H., Lim, J.-H., & Kim, J.-H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6973 · Cited by 175
Self-citationChoi, B.-H., Ahn, I.-S., Kim, Y.-H., Park, J.-W., Lee, S.-Y., Hyun, C.-K., & Do, M.-S. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.71 · Cited by 166
Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family.
Kyriakis, J. M. (1999) · Europe PMC (PubMed Central) · Cited by 165
Hu, J.-P., Nishishita, K., Sakai, E., Yoshida, H., Kato, Y., Tsukuba, T., & Okamoto, K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.013 · Cited by 156
Pereira, G. C., Branco, A. F., Matos, J. A. C., Pereira, S. L., Parke, D., Perkins, E. L., Serafim, T. L., Sardão, V. A., Santos, M. S., Moreno, A. J. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128017 · Cited by 152
Abidi, P., Zhou, Y., Jiang, J.-D., & Liu, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181761.16341.2b · Cited by 152
Steinberg, G. R. (2007) · Cell Cycle · doi:10.4161/cc.6.8.4135 · Cited by 150
Metabolic Stress Signaling Mediated by Mixed-Lineage Kinases
Jaeschke, A., & Davis, R. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.008 · Cited by 150
Chan, E. D., Winston, B. W., Uh, S., Wynes, M. W., Rose, D. M., & Riches, D. W. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.415 · Cited by 150
Chan, E. D., Winston, B. W., Uh, S., Wynes, M. W., Rose, D. M., & Riches, D. W. H. (1999) · PubMed · Cited by 139
Lee, C.-H., Chen, J., Hsiang, C., Wu, S., Wu, H.-C., & Ho, T. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.06.003 · Cited by 129
Coenen, K. R., Gruen, M. L., Chait, A., & Hasty, A. H. (2007) · Diabetes · doi:10.2337/db06-1375 · Cited by 121
Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders
Kaplan, M. S., Mutlu, E., Benson, M., Fields, J. Z., Banan, A., & Keshavarzian, A. (2006) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2006.06.005 · Cited by 119
Kim, J.-E., Kim, Y., Lee, I. K., Kim, J., Kang, Y. J., & Park, S. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071857 · Cited by 91
Self-citationWartenberg, M., Budde, P., de Marées, M., Grünheck, F., Tsang, S. Y., Huang, Y., Chen, Z., Hescheler, J., & Sauer, H. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000049348.51663.2f · Cited by 83
Liu, H.-Y., Collins, Q. F., Xiong, Y., Moukdar, F., Lupo, E. G., Liu, Z., & Cao, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609701200 · Cited by 75
Cho, B. J., Im, E. K., Kwon, J. H., Lee, K.-H., Shin, H.-J., Oh, J., Kang, S., Chung, J. H., & Jang, Y. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13249-3 · Cited by 65
Self-citationFrom Extracellular to Intracellular Targets, Inhibiting MAP Kinases in Treatment of Crohn's Disease
van den Blink, B., ten Hove, T., van den Brink, G. R., Peppelenbosch, M. P., & van Deventer, S. J. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04664.x · Cited by 27
Postischemic anti-inflammatory effects of bradykinin preconditioning
Shigematsu, S., Ishida, S., Gute, D. C., & Korthuis, R. J. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.1.h441 · Cited by 26
Cited by
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 619
Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042529 · Cited by 615
AMPK in skeletal muscle function and metabolism
Kjøbsted, R., Hingst, J. R., Fentz, J., Foretz, M., Sanz, M., Pehmøller, C., Shum, M., Marette, A., Mounier, R., Treebak, J. T., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700442r · Cited by 496
Biological properties and clinical applications of berberine
Song, D., Hao, J., & Fan, D. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0724-6 · Cited by 496
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465
Metadata
- Authors
- Jeong, H. W., Hsu, K. C., Lee, J.-W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S., & Kim, J. B.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2009-04
- Volume
- 296
- Issue
- 4
- Pages
- E955-E964
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2130478732
- Cited by
- 454
- References
- 55
- FWCI
- 18.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.